Skip to main content
Journal cover image

Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma.

Publication ,  Journal Article
Choi, BD; Suryadevara, CM; Gedeon, PC; Herndon, JE; Sanchez-Perez, L; Bigner, DD; Sampson, JH
Published in: J Clin Neurosci
January 2014

Chimeric antigen receptors (CAR)-transduced T cells hold great promise in the treatment of malignant disease. Here, we demonstrate that intracerebral injection with a human, epidermal growth factor receptor variant III (EGFRvIII)-specific, third generation CAR successfully treats glioma in mice. Importantly, these results endorse clinical translation of this CAR in patients with EGFRvIII-expressing brain tumors.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Neurosci

DOI

EISSN

1532-2653

Publication Date

January 2014

Volume

21

Issue

1

Start / End Page

189 / 190

Location

Scotland

Related Subject Headings

  • Xenograft Model Antitumor Assays
  • Transduction, Genetic
  • Receptors, Antigen, T-Cell
  • Neurology & Neurosurgery
  • Mice, SCID
  • Mice, Inbred NOD
  • Mice
  • Immunotherapy
  • Humans
  • Glioma
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Choi, B. D., Suryadevara, C. M., Gedeon, P. C., Herndon, J. E., Sanchez-Perez, L., Bigner, D. D., & Sampson, J. H. (2014). Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma. J Clin Neurosci, 21(1), 189–190. https://doi.org/10.1016/j.jocn.2013.03.012
Choi, Bryan D., Carter M. Suryadevara, Patrick C. Gedeon, James E. Herndon, Luis Sanchez-Perez, Darell D. Bigner, and John H. Sampson. “Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma.J Clin Neurosci 21, no. 1 (January 2014): 189–90. https://doi.org/10.1016/j.jocn.2013.03.012.
Choi BD, Suryadevara CM, Gedeon PC, Herndon JE, Sanchez-Perez L, Bigner DD, et al. Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma. J Clin Neurosci. 2014 Jan;21(1):189–90.
Choi, Bryan D., et al. “Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma.J Clin Neurosci, vol. 21, no. 1, Jan. 2014, pp. 189–90. Pubmed, doi:10.1016/j.jocn.2013.03.012.
Choi BD, Suryadevara CM, Gedeon PC, Herndon JE, Sanchez-Perez L, Bigner DD, Sampson JH. Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma. J Clin Neurosci. 2014 Jan;21(1):189–190.
Journal cover image

Published In

J Clin Neurosci

DOI

EISSN

1532-2653

Publication Date

January 2014

Volume

21

Issue

1

Start / End Page

189 / 190

Location

Scotland

Related Subject Headings

  • Xenograft Model Antitumor Assays
  • Transduction, Genetic
  • Receptors, Antigen, T-Cell
  • Neurology & Neurosurgery
  • Mice, SCID
  • Mice, Inbred NOD
  • Mice
  • Immunotherapy
  • Humans
  • Glioma